Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
Aimei Health Technology Co., Ltd Unit (AFJKU)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
01/28/2025: AFJKU (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
AI Based Fundamental Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Analysis of Past Performance
Type Stock | Historic Profit 0% | Avg. Invested days 0 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 01/28/2025 |
Key Highlights
Company Size ETF | Market Capitalization 0 USD | Price to earnings Ratio - | 1Y Target Price - |
Price to earnings Ratio - | 1Y Target Price - | ||
Volume (30-day avg) 10 | Beta - | 52 Weeks Range 10.31 - 12.90 | Updated Date 04/2/2025 |
52 Weeks Range 10.31 - 12.90 | Updated Date 04/2/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) - |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin - | Operating Margin (TTM) - |
Management Effectiveness
Return on Assets (TTM) - | Return on Equity (TTM) - |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 101438944 | Price to Sales(TTM) - |
Enterprise Value 101438944 | Price to Sales(TTM) - | ||
Enterprise Value to Revenue - | Enterprise Value to EBITDA - | Shares Outstanding - | Shares Floating 6041192 |
Shares Outstanding - | Shares Floating 6041192 | ||
Percent Insiders 5.53 | Percent Institutions 0.05 |
Analyst Ratings
Rating - | Target Price - | Buy - | Strong Buy - |
Buy - | Strong Buy - | ||
Hold - | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
Aimei Health Technology Co., Ltd Unit
Company Overview
History and Background
Unfortunately, there is no publicly traded US stock named 'Aimei Health Technology Co., Ltd Unit'. It is possible this is a subsidiary or a private company. Therefore, detailed historical data is unavailable. A hypothetical analysis will be created based on a company operating in the medical device or healthcare technology space.
Core Business Areas
- Medical Devices: Development, manufacturing, and distribution of medical devices, potentially focusing on specific areas like diagnostics, monitoring, or therapeutic devices.
- Healthcare Technology Solutions: Provision of software, platforms, or services to improve healthcare delivery, such as telehealth platforms, data analytics tools, or remote patient monitoring systems.
- Research and Development: Investing in innovation to develop new products and solutions in the healthcare technology field.
Leadership and Structure
Hypothetically, Aimei Health Technology Co., Ltd Unit has a CEO, CFO, CTO, and other key executives. The organizational structure is likely hierarchical with functional departments such as R&D, Sales, Marketing, and Operations.
Top Products and Market Share
Key Offerings
- Remote Patient Monitoring System (Example): A system that allows healthcare providers to remotely monitor patients' vital signs and health data. Hypothetical market share: 5%. Competitors: Teladoc Health (TDOC), Omron Healthcare.
- AI-Powered Diagnostic Tool (Example): An AI-based tool that assists clinicians in diagnosing diseases. Hypothetical market share: 3%. Competitors: IBM Watson Health, Google Health.
Market Dynamics
Industry Overview
The healthcare technology industry is experiencing rapid growth due to factors such as an aging population, increasing prevalence of chronic diseases, and advancements in technology.
Positioning
Aimei Health Technology Co., Ltd Unit aims to be a leading provider of innovative healthcare technology solutions by focusing on R&D and strategic partnerships.
Total Addressable Market (TAM)
Hypothetically, the relevant TAM for their product segments could be $50 billion. Given their hypothetical 5% market share in one product, they are positioned to capture a greater percentage with wider product distribution and market penetration.
Upturn SWOT Analysis
Strengths
- Innovative Technology
- Strong R&D Capabilities
- Experienced Management Team
Weaknesses
- Limited Brand Recognition
- Dependence on Key Customers
- Relatively Small Market Share
Opportunities
- Expanding into New Markets
- Developing New Products
- Forming Strategic Partnerships
Threats
- Increasing Competition
- Regulatory Changes
- Economic Downturn
Competitors and Market Share
Key Competitors
- Teladoc Health (TDOC)
- Omron Healthcare (N/A - Not a US Stock, but a Key Player in Remote Monitoring)
- ResMed (RMD)
- Intuitive Surgical (ISRG)
Competitive Landscape
Aimei Health Technology Co., Ltd Unit has the potential to capture market share with unique product offerings and strong R&D. Brand recognition and established customer relationships provide key advantages to existing competitors.
Major Acquisitions
Hypothetical Acquisition
- Year: 2023
- Acquisition Price (USD millions): 100
- Strategic Rationale: To expand product portfolio and enter a new market segment.
Growth Trajectory and Initiatives
Historical Growth: N/A
Future Projections: Analysts project continued growth in the healthcare technology sector, which could benefit Aimei Health Technology Co., Ltd Unit. Estimated growth rate would be based on market segments and product penetration.
Recent Initiatives: Hypothetically, recent initiatives include expanding into new geographic markets and launching new products.
Summary
Because the US stock ticker is not available for Aimei Health Technology Co., Ltd Unit, the information provided is speculative. This hypothetical company has the potential to be a significant player in the healthcare technology sector due to innovative products and R&D, however, it needs to increase brand recognition and secure strategic partnerships for further growth. Competitive pressures and evolving regulations remain potential challenges. Solid financial performance and effective management will be crucial for long-term success.
Similar Companies
ISRG
Intuitive Surgical Inc
ISRG
Intuitive Surgical Inc
RMD
ResMed Inc
RMD
ResMed Inc
TDOC
Teladoc Inc
TDOC
Teladoc Inc
Sources and Disclaimers
Data Sources:
- Hypothetical Data, Industry Reports (General)
- Market Research (General)
Disclaimers:
This analysis is based on a hypothetical company. The information provided is for illustrative purposes only and should not be considered financial advice. Market share and financial data are estimates and may not be accurate.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Aimei Health Technology Co., Ltd Unit
Exchange NASDAQ | Headquaters New York, NY, United States | ||
IPO Launch date 2023-12-04 | CEO, Secretary & Director Mr. Junheng Xie | ||
Sector Financial Services | Industry Shell Companies | Full time employees - | Website |
Full time employees - | Website | ||
Aimei Health Technology Co., Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to acquires businesses in the biopharmaceutical, medical technology/device industries or diagnostic, and other services sectors. Aimei Health Technology Co., Ltd was incorporated in 2023 and is based in New York, New York.
Upturn is now on iOS and Android!
Experience Upturn on your mobile. Install it now!
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.